The Minnesota HPV Vaccination Summit has been announced for Mon., April 25, 2016. Held on the University of Minnesota campus, the daylong meeting will feature a multidisciplinary and interprofessional panel of state and national HPV vaccination and cancer-prevention experts. Family medicine and primary care practitioners, pediatricians, OB/GYN providers, dentists, pharmacists, nurse practitioners, and others from across Minnesota who are able to endorse the vaccine are invited to participate.
The summit’s format will be similar to that of the national HPV vaccination summit held in Houston, Texas, Nov. 2015. The Houston summit brought together experts from the National Cancer Institute (NCI), the American Cancer Society, the Centers for Disease Control and Prevention, and more than 35 of the nations’ NCI-designated cancer centers. Summit participants engaged with each other to provide a snapshot of actions underway in support HPV vaccination uptake and to share results, identify new opportunities for collectively engaging in cancer-control activities related to HPV vaccination, and to identify research opportunities related to HPV vaccination.
The Minnesota summit brings together cancer experts and healthcare leaders with the goal of maximizing the success of research into the prevention and treatment of gynecologic cancers and other cancers caused by HPV infection. The Minnesota HPV Vaccination Summit is sponsored by the Gynecologic Oncology Translational Working Group, part of the Masonic Cancer Center, University of Minnesota.
Register for the MN HPV Vaccination Summit here.
The University of Minnesota Cancer Care symposium “Basic Discovery Accelerating Groundbreaking Brain Tumor Therapy” will be held May 9-10, at the Hyatt Regency in downtown Minneapolis.
This two-day event features presentations from experts in neuro-oncology and will be of interest to researchers, physicians, students, patients and families interested in neuro-oncology. Session topics include immunotherapy, physics and modeling, blood brain barrier, and genetics. CME credits are available.
Register for the Neuro-Oncology Symposium here.
The HPV vaccine could potentially reduce HPV-induced cancers by one-third, yet vaccination rates lag. An M Health physician helps lead an initiative designed to support physicians in encouraging use of the vaccine.Continue reading
Part of the work of Minnesota HPV, the study equips community healthcare providers with toolkits designed to help them in working with young patients and their families.Continue reading